A practical reference on Dual agonist: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-08-12 and is reviewed periodically as new material appears.
Verification of research-grade material involves checking purity, sequence and counter-ion content against a certificate of analysis. Reported purity figures usually reflect chromatographic area percentage and do not by themselves establish biological activity. Independent laboratories may repeat mass confirmation and peptide mapping to detect substitutions or truncations. Open questions concern how residual solvents, trace metals and subtle conformational variants affect measured behavior, and how consistently different suppliers define their specifications. Documentation of analytical methods matters as much as the headline purity number when results are compared across studies.
Routine characterization relies on reversed-phase high-performance liquid chromatography, often coupled to mass spectrometry, to confirm identity and estimate purity. Peptide mapping after enzymatic digestion verifies the amino acid sequence and locates appended groups such as the fatty acid chain. Size-exclusion chromatography detects aggregates and fragments, while ion-exchange chromatography resolves charge variants. Circular dichroism and nuclear magnetic resonance supply secondary and higher-order structural information in research settings. No single technique covers every attribute, so laboratories combine orthogonal methods and compare outcomes against a reference standard where one exists.
Research and analytical settings increasingly require documentation of peptide origin and chain of custody. Certificate of analysis documents typically report purity by chromatographic area, mass confirmation, appearance, and residual solvent or counterion content. Independent verification by an accredited laboratory is common when a material will be used in a regulated study. Open questions remain about how well compendial methods transfer between laboratories, and about which impurity thresholds are meaningful for materials not intended for clinical use.
Peptide-based pharmaceutical products such as tirzepatide require controlled temperature management to preserve structural integrity. Manufacturer labeling generally specifies refrigeration at 2 to 8 degrees Celsius before first use, with protection from light and freezing. Exposure to repeated temperature cycling can promote aggregation or deamidation, which alters the analytical profile even when the visible solution appears unchanged. Once a product is in use, the permitted storage window and temperature range are defined by the specific labeled presentation rather than by general peptide rules.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilized powder | Visual inspection serves only as a preliminary check |
| Solubility | Freely soluble in water and aqueous buffers | Gentle mixing may be needed to reach full dissolution |
| Typical storage | Minus 20 degrees Celsius or colder, desiccated, protected from light | Avoid repeated freeze-thaw cycles |
| Primary analytical method | Reversed-phase HPLC with mass detection | Purity reported as chromatographic area percent |
| Common synonyms | GIP/GLP-1 dual agonist; LY3298176 | Development codes are distinct from approved product names |
Lyophilized material is generally held at -20 degrees Celsius or lower, desiccated and protected from light, where it remains stable for extended periods. Reconstituted or ready-to-use solution is usually kept at 2 to 8 degrees Celsius with minimal agitation. Repeated freeze-thaw cycles should be avoided because they promote aggregation and reduce the soluble monomer fraction. Shipment of frozen solid commonly uses dry ice, while refrigerated liquid moves with validated cold packs. Stability beyond documented periods is not established.
Characterization of the peptide relies on reversed-phase high-performance liquid chromatography for purity and related-substance profiling, with ultraviolet detection near 214 nanometers. Mass spectrometry confirms molecular mass and reveals modifications such as oxidation or deamidation. Peptide mapping after enzymatic digestion verifies the amino acid sequence, while amino acid analysis supplies compositional data. Circular dichroism and infrared spectroscopy are used to assess secondary structure, particularly the alpha-helical content that influences aggregation behavior in solution.
Common degradation routes include hydrolysis of labile amide bonds, deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and non-covalent aggregation. Aggregates can form during freeze-thaw cycling, at elevated pH, or when peptide concentration is high. Each route produces characteristic chromatographic or mass shifts that are tracked during stability studies. Whether a given minor impurity alters biological activity is often an open question, and specification limits are typically set on identity and purity rather than on functional data for trace species.
Dual agonism at the GIP and GLP-1 receptors underlies the observed pharmacology. Activation of GLP-1 receptors raises glucose-dependent insulin release, lowers glucagon secretion, slows gastric emptying and reduces appetite. GIP receptor activation contributes additional effects on adipose tissue and on energy balance, and the combined action on appetite appears larger than either pathway alone in animal models. Signalling bias and the relative contribution of each receptor arm to weight-related effects remain areas of active investigation.
Structure-activity work shows that fatty acid length, linker chemistry and the position of acylation all influence albumin affinity and receptor potency. Plasma protein binding exceeds 99 percent, which restricts distribution and slows renal clearance. Degradation proceeds largely through general proteolysis and fatty acid oxidation rather than cytochrome P450 metabolism, so exposure to common oxidative drug interactions is limited. Whether these clearance routes vary meaningfully between individuals is not fully established.
The molecule is a synthetic 39-amino-acid peptide whose backbone derives from the sequence of human glucose-dependent insulinotropic polypeptide, with several substitutions that raise metabolic stability and shift receptor preference. A C20 fatty diacid is attached through a short linker to a lysine side chain, a modification that increases binding to serum albumin. The reported monoisotopic mass is approximately 4813 Da. Near neutral pH the peptide carries a net negative charge, and the lipid tail makes the molecule markedly more hydrophobic than the unmodified parent sequence.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Tirzepatide is a synthetic peptide developed as a dual agonist at the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. Its structure is built on a GIP-derived backbone with non-natural amino acid substitutions and a fatty diacid side chain that promotes albumin binding and slows clearance. That modification supports once-weekly subcutaneous dosing. Registrational trial programs reported reductions in body weight and glycated hemoglobin alongside the drug's glycemic effects.
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
An isotope (nuclide) is specified by the name of the element (which implies the atomic number) followed by a hyphen and the mass number (e.g. helium-3, helium-4, carbon-12, carbon-14, uranium-235 and uranium-239). When a element symbol is used, e.g. "C" for carbon, it is standard to use "AZE notation" which has the form AZE, where A is the mass number written as a superscript, Z is the atomic number written as a subscript, and E is the element symbol (e.g. 32He, 42He, 126C, 146C, 23592U, and 23992U). Because the atomic number is already fixed by the element symbol, it is common to state only the mass number in the superscript and leave out the atomic number subscript (e.g. 3He, 4He, 12C, 14C, 235U, and 239U). The letter m (for metastable) is appended after the mass number to indicate a nuclear isomer, a metastable or energetically excited nuclear state (as opposed to the lowest-energy ground state), for example 180m73Ta (tantalum-180m); a number can be appended to it to distinguish different metastable states, though this is rare in practice. The common pronunciation of the AZE notation is different from how it is written: 42He is commonly pronounced helium-four instead of four-two-helium, and 23592U uranium two-thirty-five (American English) or uranium-two-three-five (British) instead of 235-92-uranium or 235-uranium. This is not an error but the original spoken usage for isotope names, originating before AZE notation became established.
== History == 2000: Four scientists from what was then the Agricultural University of Norway (NLH), now the Norwegian University of Life Sciences (UMB) had the idea of replacing traditional date-stamping with something that can give a more correct indication of remaining shelf life for temperature sensitive products, such as food and pharmaceuticals. 2001: The fundamental principles for a shelf-life indicator were verified in the laboratory. The company TimeTemp AS, now Keep-it Technologies, was founded in 2001 to develop the technology into a commercial product. 2003: TimeTemp comes in second place in DNB’s national innovation competition. 2003-2007: The technology is tested and developed in the university's laboratories, and a working laboratory prototype is created. Keep-it Technologies is granted a patent in a number of different countries, including the US, Canada, Australia and New Zealand. 2007-2009: With support from the Research Council of Norway, Keep-it Technologies initiates an R&D project to develop the technology from laboratory prototype to an industrial prototype, and test it on real products through a professional cold chain. 2010-2011: The company raises new investment capital and initiates an IFU project that develops the first consumer version of the indicator. The indicator is tested on the first products in the Norwegian grocery market. 2012: Keep-it indicator is commercialized in Norway with the Norwegian retailer, Rema 1000. 2018: Keep-it has indicators on 30 different fresh products at Rema 1000, Kolonial.no and Oslo University Hospital.
India is a federal union comprising 28 states and 8 union territories. All states, as well as the union territories of Jammu and Kashmir, Puducherry and the National Capital Territory of Delhi, have elected legislatures and governments following the Westminster system. The remaining five union territories are directly ruled by the central government through appointed administrators. In 1956, under the States Reorganisation Act, states were reorganised on a linguistic basis. Over a quarter of a million local government bodies operate at the city, town, district, block, and village levels.
== Career == On 18 July 1985, he co-founded the Belgian biotech company Innogenetics, together with Erik Tambuyzer and Hugo Van Heuverswyn and has been its chairman since then. Besides Innogenetics, he founded several clinical laboratories. He is an international centralized clinical laboratory. He is also CEO of Gengest BVBA (management company), Biovest CVA, LMA BVBA, Laboraco BVBA, and he is director of DSJ Bruxelles NV and Oystershell NV. Rudi Mariën is a member of the American Association for Clinical Chemistry.
In the synthesis of DNA templated combinatorial libraries, the ability of the DNA double helix to direct region-specific chemical reactions is harnessed by Gartner et al. The DNA- linked reagents are kept in close proximity. This is equivalent to the virtual increase of local concentration that is nearly constant within a distance of 30 nucleotides. The proximity effect helps reactions to proceed. Two libraries are synthesized. A template library containing at one end one of the BBs and its code followed by two annealing regions for the codes of the BBs of the two reagent libraries. Each of the two reagent libraries contains a coding oligonucleotide linked with cleavable bonds to the reagent (BB) capable of forming a bond with the already linked BB taking advantage of the proximity effect. The synthesis is realized in two steps as shown in the figure. Each step has three operations: mixing, annealing, coupling-cleaving.
Sources: en.wikipedia.org
== History == Barbituric acid was first synthesized 27 November 1864, by German chemist Adolf von Baeyer, and later perfected in 1879 by the French chemist Edouard Grimaux, who developed and improved the synthesis. This was done by condensing urea with diethyl malonate. There are several stories about how the substance got its name. The most likely story is that Baeyer and his colleagues went to celebrate their discovery in a tavern where the town's artillery garrison were also celebrating the feast of Saint Barbara – the patron saint of artillerymen. An artillery officer is said to have christened the new substance by amalgamating Barbara with urea. Another story holds that Baeyer synthesized the substance from the collected urine of a Munich waitress named Barbara. No substance of medical value was discovered, however, until 1902 when two German scientists working at Bayer, Emil Fischer and Joseph von Mering, discovered that barbital was very effective in putting dogs to sleep. Barbital was then marketed by Bayer under the trade name Veronal. It is said that Mering proposed this name because the most peaceful place he knew was the Italian city of Verona. In 1912, Bayer introduced another barbituric acid derivative, phenobarbital, under the trade name Luminal, as a sedative–hypnotic. It was not until the 1950s that the behavioral disturbances and physical dependence potential of barbiturates became recognized. Since the 1970s, most barbiturates were replaced by benzodiazepines.
In late 1807, Spanish and Napoleonic forces threatened the security of continental Portugal, causing Prince Regent John, in the name of Queen Maria I, to move the royal court from Lisbon to Rio de Janeiro. There they established some of Brazil's first financial institutions, such as its local stock exchanges and its National Bank, additionally ending the Portuguese monopoly on Brazilian trade and opening Brazil's ports to other nations. In 1809, in retaliation for being forced into exile, the Prince Regent ordered the conquest of French Guiana. With the end of the Peninsular War in 1814, the courts of Europe demanded that Queen Maria I and Prince Regent John return to Portugal, deeming it unfit for the head of an ancient European monarchy to reside in a colony. In 1815, to justify continuing to live in Brazil, where the royal court had thrived for six years, the Crown established the United Kingdom of Portugal, Brazil and the Algarves, thus creating a pluricontinental transatlantic monarchic state. However, the leadership in Portugal, resentful of the new status of its larger colony, continued to demand the return of the court to Lisbon (see Liberal Revolution of 1820). In 1821, acceding to the demands of revolutionaries who had taken the city of Porto, John VI departed for Lisbon. There he swore an oath to the new constitution, leaving his son, Prince Pedro de Alcântara, as Regent of the Kingdom of Brazil.
Body mass index (BMI) is acceptable for determining obesity for children two years of age and older. It is determined by the ratio of weight to height. The normal range for BMI in children vary with age and sex. While a BMI above the 85th percentile is defined as overweight, a BMI greater than or equal to the 95th percentile is defined as obesity by the Centers for Disease Control and Prevention (CDC). Obesity is further categorized as class 1 obesity with BMI at or above the 95th percentile to 119% of the 95th percentile, class 2 obesity with a BMI 120 to 139% of the 95% percentile and class 3 obesity which is 140% or greater of the 95th percentile. The CDC has published tables for determining this in children. The US Preventive Service Task Force reported that not all children with a high BMI need to lose weight, however. High BMI can identify a possible weight problem, but does not differentiate between fat or lean tissue. Additionally, BMI may mistakenly rule out some children who do have excess adipose tissue. It is therefore beneficial to supplement the reliability of a BMI diagnosis with additional screening tools such as adipose tissue or skin fold measurements.
RCH=CH2 + H2 + CO2 → RCH2−CH2CO2H Other methods, e.g. the Koch reaction, effect "net" carboxylation involve the use of carbon monoxide, either directly or generated in situ. These methods are variants of carbonylation reactions. Carboxylation of epoxides gives cyclic carbonates. Such reactions are catalyzed by N-Heterocyclic carbenes and catalysts based on silver.
In most of the world, a "hot dog" is recognized as a sausage in a bun, but the type varies considerably. The name is often applied to something that would not be described as a hot dog in North America. For example, in New Zealand a "hot dog" is a battered sausage, often on a stick, which is known as a corn dog in North America; an "American hot dog" is the version in a bun.
Sources: en.wikipedia.org
Glutathione S-transferase A1 is an enzyme that in humans is encoded by the GSTA1 gene. Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. These enzymes function in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding these enzymes are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of some drugs. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase belonging to the alpha class. The alpha class genes, located in a cluster mapped to chromosome 6, are the most abundantly expressed glutathione S-transferases in liver (hepatocytes) and kidney (proximal tubules). In addition to metabolizing bilirubin and certain anti-cancer drugs in the liver, the alpha class of these enzymes exhibit glutathione peroxidase activity, thereby protecting the cells from reactive oxygen species and the products of peroxidation.
The drug udenafil is marketed under the trade name Zydena. It is within the PDE5 inhibitor class (which also includes avanafil, sildenafil, tadalafil, and vardenafil). Like other PDE5 inhibitors, it is used to treat erectile dysfunction. Udenafil was developed by Dong-A Pharmaceutical. It has fairly rapid onset of action (peak plasma concentration after 1 to 1.5 hours), and has long duration of action (plasma half-life of 11 to 13 hours). Udenafil's pharmacokinetics allows once-daily dosage (in addition to on-demand use). Typical doses are 100 and 200 mg. Udenafil is available in Korea, Russia, and the Philippines. It has not yet been approved for use in the United States by the U.S. Food and Drug Administration.
An electrical repeater, or synchro, was added to the gonio dial. To measure the range, a new dial was added that moved a mechanical marker to a selected blip on the display. When a particular target was properly selected, the operator pushed a button to activate the fruit machine, which then read these inputs. In addition to the inputs, the fruit machine also had a series of local corrections for both angle and altitude, as measured by calibration flights and stored in the machine in telephone uniselectors. These corrections were automatically added to the calculation, eliminating the time-consuming lookup of these numbers from tables. The output was the altitude, which then allowed the plotters to determine the proper over-ground distance to the target. Later versions of the fruit machine were upgraded to directly output the position of the aircraft with no manual operation. Using the same buttons to send settings to the machine, the operator simply triggered the system and the outputs were used to drive a T-square-like indicator on the chart, allowing the operator to read the calculated location directly. This reduced the number of people needed at the station and allowed the station to be reorganized into a much more compact form. No longer did the operator call readings out to the plotters; now they sat directly beside the plotting table so they could see if the results looked right, while the tellers could see the plot and call it into the area plotting room.
Artificial bone can be created from ceramics such as calcium phosphates (e.g. hydroxyapatite and tricalcium phosphate), Bioglass and calcium sulfate; all of which are biologically active to different degrees depending on solubility in the physiological environment. These materials can be doped with growth factors, ions such as strontium or mixed with bone marrow aspirate to increase biological activity. Some authors believe this method is inferior to autogenous bone grafting; however, infection and rejection of the graft is much less of a risk, and the mechanical properties such as Young's modulus are comparable to bone. The presence of elements such as strontium can result in higher bone mineral density and enhanced osteoblast proliferation in vivo.
Sources: en.wikipedia.org
Liquid chromatography combined with mass spectrometry is the most common approach. Digestion followed by peptide mapping verifies the sequence and modification sites. Results are judged against a reference standard or a theoretically calculated mass.
Lower temperatures slow most degradation routes, and storage at minus twenty degrees Celsius or below is standard for lyophilized material. Repeated warming and cooling imposes stress on the molecule. Dissolved samples deteriorate faster and are usually handled over shorter periods.
It normally reflects the relative chromatographic area of the principal peak. It does not capture every possible impurity or demonstrate biological function. Additional methods are required to describe a sample completely.
The peptide backbone and its fatty acid side chain are susceptible to degradation at elevated temperatures. Refrigeration slows hydrolysis, oxidation, and aggregation processes. Labeled storage ranges reflect stability data generated under defined conditions.